Skip to main content

Booth Bruce's Form 4 filing

Kymera Therapeutics, Inc.KYMR · filed Jun 25, 2026

Accession no.
0001451612-26-000016
Filed
Jun 25, 2026
Trade date
Jun 25, 2026
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 22 non-derivative transactions. Open-market sales total $34.8M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Booth BruceCIK 0001451612Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 25, 2026Common StockSSaleDisposed−37,179$119.71F2−$4,450,698.093,075,906Indirect
Jun 25, 2026Common StockSSaleDisposed−112,299$120.66F4−$13,549,997.342,963,607Indirect
Jun 25, 2026Common StockSSaleDisposed−40,774$121.38F5−$4,949,148.122,922,833Indirect
Jun 25, 2026Common StockSSaleDisposed−4,977$122.67F6−$610,528.592,917,856Indirect
Jun 25, 2026Common StockSSaleDisposed−10,860$123.62F7−$1,342,513.22,906,996Indirect
Jun 25, 2026Common StockSSaleDisposed−11,711$124.61F8−$1,459,307.712,895,285Indirect
Jun 25, 2026Common StockSSaleDisposed−3,716$125.82F9−$467,547.122,891,569Indirect
Jun 25, 2026Common StockSSaleDisposed−1,609$126.71F10−$203,876.392,889,960Indirect
Jun 25, 2026Common StockSSaleDisposed−25,075$127.37F11−$3,193,802.752,864,885Indirect
Jun 25, 2026Common StockSSaleDisposed−2,197$128.69F12−$282,731.932,862,688Indirect
Jun 25, 2026Common StockSSaleDisposed−337$129.61F13−$43,678.572,862,351Indirect
Jun 25, 2026Common StockSSaleDisposed−5,144$119.71F2−$615,788.24559,524Indirect
Jun 25, 2026Common StockSSaleDisposed−15,660$120.66F4−$1,889,535.6543,864Indirect
Jun 25, 2026Common StockSSaleDisposed−5,689$121.38F5−$690,530.82538,175Indirect
Jun 25, 2026Common StockSSaleDisposed−698$122.67F6−$85,623.66537,477Indirect
Jun 25, 2026Common StockSSaleDisposed−1,517$123.62F7−$187,531.54535,960Indirect
Jun 25, 2026Common StockSSaleDisposed−1,639$124.61F8−$204,235.79534,321Indirect
Jun 25, 2026Common StockSSaleDisposed−522$125.82F9−$65,678.04533,799Indirect
Jun 25, 2026Common StockSSaleDisposed−223$126.71F10−$28,256.33533,576Indirect
Jun 25, 2026Common StockSSaleDisposed−3,507$127.37F11−$446,686.59530,069Indirect
Jun 25, 2026Common StockSSaleDisposed−305$128.69F12−$39,250.45529,764Indirect
Jun 25, 2026Common StockSSaleDisposed−46$129.61F13−$5,962.06529,718Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.08 to $120.0798 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (2) and (4) through (13).

Referenced by the price of 2 transactions in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.08 to $121.0794 inclusive.

Referenced by the price of 2 transactions in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.08 to $122.0731 inclusive.

Referenced by the price of 2 transactions in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.0858 to $123.08 inclusive.

Referenced by the price of 2 transactions in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.09 to $124.08 inclusive.

Referenced by the price of 2 transactions in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.09 to $125.0292 inclusive.

Referenced by the price of 2 transactions in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.1194 to $126.115 inclusive.

Referenced by the price of 2 transactions in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.13 to $127.0511 inclusive.

Referenced by the price of 2 transactions in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.30 to $128.2975 inclusive.

Referenced by the price of 2 transactions in Table I.

F12

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.3008 to $129.2819 inclusive.

Referenced by the price of 2 transactions in Table I.

F13

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.3041 to $130.05 inclusive.

Referenced by the price of 2 transactions in Table I.

Remarks

Due to the 30 line limitation in Table I, this report is being filed across two forms. This is the second of two filings.

Read the full filing on SEC EDGAR (opens in a new tab)